Advanced gastroesophageal adenocarcinoma
Clinical trials for Advanced gastroesophageal adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Advanced gastroesophageal adenocarcinoma trials appear
Sign up with your email to follow new studies for Advanced gastroesophageal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for minority patients with hard-to-treat stomach and esophageal cancers
Disease control Recruiting nowThis study is testing a drug called tislelizumab combined with chemotherapy as a first treatment for people with advanced stomach or esophageal cancer that cannot be removed by surgery or has spread. It focuses on racial and ethnic minority groups in the US, including Black, Hisp…
Matched conditions: ADVANCED GASTROESOPHAGEAL ADENOCARCINOMA
Phase 2 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a new tracer make tumors light up on scans?
Diagnosis Recruiting nowThis trial tests an experimental imaging agent called [68Ga]Ga-DWJ155 in adults with advanced cancers of the breast, lung, or stomach. The agent is designed to attach to tumor cells and show up on PET scans, helping doctors see where cancer has spread. Researchers will measure ho…
Matched conditions: ADVANCED GASTROESOPHAGEAL ADENOCARCINOMA
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Sep 09, 2026 17:00 UTC